APGE
NASDAQ · Biotechnology
Apogee Therapeutics Inc
$134.84
+0.35 (+0.26%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+105.86%
1Y
+289.15%
YTD
+77.94%
Open$134.65
Previous Close$134.49
Day High$134.88
Day Low$134.47
52W High$134.58
52W Low$34.34
Volume—
Avg Volume1.27M
Market Cap10.17B
P/E Ratio—
EPS$-4.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$73.88
Above
SMA 200
$52.13
Above
RSI (14)
48.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
21 analysts
Price Target
-24.7% upside
Current
$134.84
$134.84
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 911.35M | 871.62M | 948.06M |
| Net Income | -243,438,723 | -174,175,180 | -203,637,440 |
| Profit Margin | -26.7% | -20.0% | -21.5% |
| EBITDA | -267,934,128 | -228,786,100 | -261,593,713 |
| Free Cash Flow | -101,879,133 | -97,401,406 | -128,866,616 |
| Rev Growth | +22.2% | +5.3% | +12.3% |
| Debt/Equity | 0.88 | 0.85 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |